Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
3 E Network Technology Group Limited outlined its full-stack AI storage strategy focusing on enterprise memory and storage modules, proprietary SSD development, and all-flash storage servers. This initiative aims to address growing data throughput demands in AI with integrated hardware solutions, support its global AI data center expansion, and exp…
Solaris Energy Infrastructure (NYSE: SEI) reported raised Adjusted EBITDA guidance for the third and fourth quarters of 2026 and provided an initial projection for the first quarter of 2027. The stock climbed about 6% on the news as the company cited stronger contributions from core power services and better-than-expected results from recently acqu…
GE Aerospace agreed to acquire Consolidated Precision Products from Warburg Pincus and Berkshire Partners for $11.75 billion. The Cleveland-based castings and sub-assemblies manufacturer, a long-time GE supplier with about 6,600 employees across more than 20 facilities, will be combined with GE Aerospace operations to expand capacity and accelerate…
Intel shares rose sharply in pre-market trade after supply-chain sources reported the company will raise PC CPU prices by about 10% in early October, part of a broader pricing strategy to improve gross margins. The move coincided with an analyst upgrade from Northland and a manufacturing milestone for Intel Foundry using High NA EUV lithography, cr…
Inhibrx Biosciences saw its stock climb after the company disclosed positive Phase 2 results from the HexAgon study evaluating INBRX-106 in combination with pembrolizumab for first-line, PD-L1 positive metastatic or unresectable recurrent head and neck squamous cell carcinoma. The combo produced higher confirmed objective response and six-month pro…
Rigetti Computing's stock jumped in pre-market trading after the company finalized a $100 million CHIPS Act award from the U.S. Department of Commerce. The binding agreement, executed through a Rigetti subsidiary, funds three R&D initiatives aimed at overcoming scaling bottlenecks in superconducting quantum hardware and includes a minority, non-con…
Airbnb shares climbed 0.6% in pre-market trading after Raymond James elevated the stock from Market Perform to Outperform and assigned a $200 price target, citing an "AI Founder Mode" thesis. The upgrade, paired with CEO Brian Chesky's scheduled presentation at the Goldman Sachs Communacopia + Technology Conference, and solid Q2 2026 results are ci…
Clearmind Medicine Inc. announced Yale University's IRB approval to initiate patient recruitment for Parts B and C of its Phase I/II clinical trial evaluating CMND-100, a non-hallucinogenic psychedelic-derived drug candidate targeting Alcohol Use Disorder. This milestone follows positive safety results from Part A, allowing accelerated enrollment a…
Morgan Stanley downgraded Peloton to Underweight from Equal Weight, with analyst Nathan Feather cutting his price target to $4.50 and reducing fiscal 2027 and 2028 estimates. Feather highlighted a marked contraction at the top of the funnel, steep declines in gross additions and falling connected fitness subscriber growth in fiscal 2026. He pointed…
Peloton stock fell sharply in pre-market trading after Morgan Stanley downgraded the company and cut its price target, while UBS trimmed earnings estimates and lowered its target. Analysts cited sustained weakness in subscriber growth and collapsing customer additions. Concurrent insider selling and a lack of offsetting market support contributed t…
IonQ shares climbed after the company updated its full-year 2026 revenue guidance to $450 million-$460 million following the completion of its acquisition of SkyWater Technology. The outlook incorporates SkyWater’s contributions from the July 31, 2026 closing through year-end and removes estimated intercompany revenue tied to prior commercial arran…
Qualcomm aims to build a meaningful data-center business and management has stated a goal of $15 billion in data center revenue within three years. With a market cap near $177B, strong free cash flow and attractive multiples relative to what a scaled data-center franchise would justify, this trade buys the thesis now and targets a re-rate as hypers…
Bloom Energy (BE) is showing the makings of an AI-memory-style frenzy: strong backlog, accelerating revenue guidance, healthy free cash flow, and technical momentum. Valuation is rich, but a disciplined swing trade can capture upside to prior highs while limiting downside. Entry $270.00, stop $235.00, target $350.00.
Nvidia reported another powerful quarter and sits on enormous cash flow, yet recent headlines - notably the proposed $12.93B Hugging Face buyout and outsized insider selling - create a risk-off dynamic that could pressure the stock over the next 45 trading days. This trade idea lays out a mid-term (45 trading days) short with a specific entry, stop…
Pyxis Oncology has appointed Thomas Civik as its Chief Executive Officer and Chairman of the Board, marking a leadership transition as the company advances key clinical milestones for its lead candidate MICVO, a novel antibody-drug conjugate for difficult-to-treat cancers. Civik brings significant industry experience, previously leading successful …
Artiva Biotherapeutics announced plans to initiate a Phase 3 registrational trial in refractory rheumatoid arthritis (RA) during the second half of 2026, alongside updated clinical data disclosures from their ongoing Phase 2a basket trial in RA, Sjögren disease, and systemic sclerosis. The company expects to present data from at least 20 RA patient…
CervoMed Inc., a clinical-stage biotech developing treatments for age-related brain disorders, announced management's participation in major September investor conferences. The company highlighted its lead drug candidate neflamapimod's progress, including a completed Phase 2b trial in dementia with Lewy bodies (DLB), discussions with the FDA on reg…
Nasus Pharma Ltd., a clinical-stage biopharmaceutical company specializing in intranasal drug delivery, announced it will participate in the upcoming H.C. Wainwright 28th Annual Global Investment Conference in New York. Management will present the company’s progress on its lead intranasal epinephrine product candidate NS002 and other pipeline devel…
BioVie Inc. announced progress in its Phase 3 clinical development program for bezisterim, a drug candidate for Parkinson's disease. The company is working with the FDA to finalize a trial design that includes motor symptom improvement as a primary endpoint and non-motor symptom improvement as a co-primary or secondary endpoint based on positive Ph…
BrainsWay Ltd. reported positive results from a peer-reviewed pilot study on their Deep Transcranial Magnetic Stimulation (Deep TMS) technology treating patients with Major Depressive Disorder and early-stage Alzheimer’s disease. The study showed an 83.3% response rate and 50% remission rate in depressive symptoms, alongside notable neurophysiologi…
BriaCell Therapeutics announced that the Memorial Sloan Kettering Cancer Center has joined its ongoing Phase 3 clinical trial of Bria-IMT combined with an immune checkpoint inhibitor for metastatic breast cancer. This expands patient access across over 80 clinical sites in 15 states and follows recent positive Phase 2 survival data and FDA Fast Tra…
OptimizeRx Corp., a healthcare technology company specializing in AI-driven engagement platforms for life sciences brands, announced its participation in the upcoming Lake Street Capital Best Ideas Growth Conference. The event provides an opportunity for management to connect with investors and showcase their innovative healthcare marketing solutio…
Bread Financial Holdings, a tech-forward financial services company providing payment, lending, and saving solutions to millions of U.S. consumers, announced its participation in the upcoming Barclays 24th Annual Global Financial Services Conference. The company's EVP and CFO will engage in a fireside chat highlighting strategic and financial topic…
Cognition Therapeutics announced that its CEO, Lisa Ricciardi, will present at the H.C. Wainwright Global Investment Conference to discuss the development progress of zervimesine (CT1812), their investigational drug for Alzheimer's disease and dementia with Lewy bodies. The company is advancing zervimesine into late-stage clinical trials based on p…
Medicus Pharma Ltd. announces a strategic transformation to become a precision oncology-led biotechnology company, prioritizing clinical development of CD228V, a second-generation antibody-drug conjugate targeting CD228 in solid tumors, with initial trials focused on melanoma. The company also plans to focus SkinJect development on Gorlin syndrome …
